Harbin, Heilongjiang, China Harbin Gloria Pharmaceuticals is the famous Corporate Investor, which was founded in 2000. The company was established in Asia in China. The main office of represented Corporate Investor is situated in the Harbin.
The common things for fund are deals in the range of more than 100 millions dollars. The high activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.
Among the most popular fund investment industries, there are Health Care, Mobile. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Proteus Digital Health
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Harbin Gloria Pharmaceuticals, startups are often financed by Yuan Capital, Silicon Valley Bank, Sailing Capital.
Related Funds
| Fund Name | Location |
| Automattic | California, San Francisco, United States |
| BaseKit | England, London, United Kingdom |
| Bisque | Mauritius, Moka, Moka |
| Defiance Capital | New York, New York, United States |
| Genuity | - |
| Matignon Investissement & Gestion | France, Ile-de-France, Paris |
| Nelson Investments | British Columbia, Canada, Vancouver |
| Novo Seeds | Capital Region of Denmark, Copenhagen, Denmark |
| Shijiazhuang Hongtu Jishen Chuangye Touzi Co., Ltd. | China, Hebei, Shijiazhuang |
| Thompson Taraz Managers | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $1M | 02 Dec 2016 | Shangcheng District, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $1M | 02 Dec 2016 | Shangcheng District, Zhejiang, China |
